Rocket Lab Corporation (NASDAQ:RKLB – Get Free Report)’s share price was up 1.1% during mid-day trading on Thursday after Berenberg Bank upgraded the stock to a strong-buy rating. The stock traded as high as $64.90 and last traded at $63.81. 18,596,813 shares traded hands during mid-day trading, a decline of 20% from the average session volume of 23,305,494 shares. The stock had previously closed at $63.10.
Other equities research analysts also recently issued research reports about the stock. Stifel Nicolaus set a $132.00 price target on shares of Rocket Lab in a research note on Thursday, June 4th. Roth Capital set a $110.00 target price on Rocket Lab in a report on Tuesday, August 11th. Wall Street Zen downgraded Rocket Lab from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Deutsche Bank Aktiengesellschaft boosted their price target on Rocket Lab from $73.00 to $120.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Finally, KeyCorp reiterated an “overweight” rating on shares of Rocket Lab in a research note on Tuesday, August 11th. Four investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $108.83.
Get Our Latest Stock Report on RKLB
Insider Buying and Selling
Key Rocket Lab News
Here are the key news stories impacting Rocket Lab this week:
- Positive Sentiment: Berenberg upgraded Rocket Lab to “strong buy.” The bank cited the expanding space economy and the company’s growth prospects, helping improve sentiment after the stock’s sharp recent decline. Why Is RKLB Stock Rising Today and How Much Upside Do Analysts See?
- Positive Sentiment: ARK Invest purchased 705,102 Rocket Lab shares across two trading sessions, according to fund disclosures. Cathie Wood’s buying may be viewed as validation of Rocket Lab’s long-term potential and could attract additional momentum-oriented investors. Cathie Wood Just Bought 705,102 Shares of a Rocket Company 50 Times Smaller Than SpaceX
- Positive Sentiment: Rocket Lab’s commercial base remains substantial. Articles highlighted nearly $2.4 billion in launch backlog, a new major launch contract and the company’s 94th successful launch, including a perfect record on Synspective missions and 16 additional missions booked through 2030. Rocket Lab Scores 94th Launch Win
- Neutral Sentiment: Neutron remains the central investment catalyst. The reusable medium-lift rocket could significantly expand Rocket Lab’s addressable market, but reports suggest its first launch could slip into 2027. The delay would give the company more time for testing but postpone a potentially transformative revenue opportunity. Peter Beck’s Neutron Rocket Could Slip to 2027
- Negative Sentiment: Investors remain concerned about valuation and cash use. Rocket Lab has fallen roughly 49% over three months, while spending ahead of Neutron’s debut. The company remains unprofitable, and its high valuation leaves limited room for execution setbacks. How Long Can Rocket Lab Stock Wait on Neutron?
- Negative Sentiment: Competitive and governance concerns persist. Blue Origin’s win of NASA’s $700 million Mars communications contract highlights intense competition, while a reported $8.8 million CFO share sale and prior analyst skepticism add to investor caution.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. California State Teachers Retirement System increased its position in Rocket Lab by 12,984.2% in the 2nd quarter. California State Teachers Retirement System now owns 96,179,045 shares of the rocket manufacturer’s stock valued at $9,776,600,000 after acquiring an additional 95,443,970 shares in the last quarter. BlackRock Inc. acquired a new position in shares of Rocket Lab during the second quarter worth approximately $4,124,970,000. Bank of New York Mellon Corp bought a new stake in shares of Rocket Lab during the second quarter valued at approximately $245,764,000. Norges Bank bought a new stake in shares of Rocket Lab during the fourth quarter valued at approximately $341,036,000. Finally, Bank of America Corp DE acquired a new stake in shares of Rocket Lab in the second quarter valued at approximately $437,280,000. Institutional investors and hedge funds own 71.78% of the company’s stock.
Rocket Lab Trading Up 0.7%
The company has a quick ratio of 4.98, a current ratio of 5.48 and a debt-to-equity ratio of 0.01. The business’s fifty day moving average is $75.23 and its two-hundred day moving average is $84.74. The firm has a market cap of $38.45 billion, a price-to-earnings ratio of -237.99 and a beta of 2.60.
Rocket Lab (NASDAQ:RKLB – Get Free Report) last posted its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%.The firm had revenue of $234.07 million for the quarter, compared to analyst estimates of $231.62 million. Equities analysts anticipate that Rocket Lab Corporation will post -0.2 earnings per share for the current fiscal year.
About Rocket Lab
Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.
Recommended Stories
- Five stocks we like better than Rocket Lab
- Merchants Bancorp’s Rally Is Testing How Much Risk Investors Will Overlook
- Lululemon’s Earnings Beat Hid a Bigger Problem for Its Turnaround Story
- MarketBeat Week in Review – 08/31 – 09/04
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
Receive News & Ratings for Rocket Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket Lab and related companies with MarketBeat.com's FREE daily email newsletter.
